Oxygen Nanocarriers for Improving Cardioplegic Solution Performance: Physico-Chemical Characterization

M Tannous, G Hoti, F Trotta, R Cavalli… - International Journal of …, 2023 - mdpi.com
Nanocarriers for oxygen delivery have been the focus of extensive research to ameliorate
the therapeutic effects of current anti-cancer treatments and in the organ transplant field. In …

Endothelial cell toxicity of solid-organ preservation solutions

UO von Oppell, S Pfeiffer, P Preiss, T Dunne… - The Annals of thoracic …, 1990 - Elsevier
Endothelial cell damage caused by myocardial cardioplegic solutions (Bretschneider HTK
and St. Thomas' Hospital No. 2) or renal and hepatic cold storage solutions (modified Collins …

Ex-vivo perfusion as a successful strategy for reduction of ischemia-reperfusion injury in prolonged muscle flap preservation–a gene expression study

AS Kruit, L Smits, A Pouwels, MCJM Schreinemachers… - Gene, 2019 - Elsevier
Introduction With the introduction of vascularized composite allotransplantation (VCA) as
new surgical technique, the need arose for strategies that could safely prolong graft …

A comparison of intracellular solutions for donor heart preservation

PJ Hendry, RS Labow, WJ Keon - The Journal of Thoracic and …, 1993 - Elsevier
Numerous solutions have been advocated for the preservation of donor hearts, and there
has been much interest in universal and intracellular preservation solutions. This study …

[HTML][HTML] Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischemia in the rat

R Bessho, DJ Chambers - The Journal of Thoracic and Cardiovascular …, 2002 - Elsevier
Objective: We previously showed that arrest with multidose infusions of high-dose (1
mmol/L) esmolol (an ultra-short-acting β-blocker) in oxygenated Krebs-Henseleit buffer …

The contribution of Na/H exchange to ischemia-reperfusion injury after hypothermic cardioplegic arrest

T Yamauchi, H Ichikawa, Y Sawa, N Fukushima… - The Annals of thoracic …, 1997 - Elsevier
Background. Na+/H+ exchange has been reported to be one of the key mechanisms in
myocardial ischemia-reperfusion injury. However, the effect of temperature on Na+/H+ …

Cardioplegia with an extracellular formulation

DJ Chambers, MV Braimbridge - Ischemia-reperfusion in cardiac surgery, 1993 - Springer
The clinical use of cardioplegia is now accepted world-wide for all aspects of cardiac
surgery. Myocardial protection can be achieved with a number of cardioplegic solutions but …

Effect of pH shifts induced by oxygenating crystalloid cardioplegic solutions

UO Von Oppell, LM King, EF Du Toit, P Owen… - The Annals of thoracic …, 1991 - Elsevier
Oxygenation of a bicarbonate-containing crystalloid cardioplegic solution alters the partial
pressure of both oxygen (O 2) and carbon dioxide (CO 2). Therefore, oxygenating St …

[PDF][PDF] Effects of original crystalloid cardioplegia followed by additional blood cardioplegia: treatments for prolonged cardiac arrest

S Ishikawa, K Ueda, K Neya, K Abe, S Kugawa… - Ann Thorac Cardiovasc …, 2010 - atcs.jp
Purpose: The efficacy of combination treatment of original cold crystalloid cardioplegia (SHA
solution; St. Thomas+ Histidine+ ATP+ oxygen) and additional blood cardioplegia was …

[图书][B] Experimentelle Untersuchungen zu den kardioprotektiven Eigenschaften von Cardioplexol während herzchirurgischer Eingriffe bei einem akuten …

C Erath - 2023 - jlupub.ub.uni-giessen.de
Cardioplexol ist eine kristalloide Kardioplegielösung, die sich besonders durch ihr geringes
Verabreichungsvolumen, den schnellen Wirkungseintritt sowie eine verlängerte …